Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.

van der Gaast, A

Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 1994 - 858-60 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0923-7534

10.1093/oxfordjournals.annonc.a059020 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Carboplatin--administration & dosage
Disease-Free Survival
Etoposide--administration & dosage
Female
Humans
Middle Aged
Neoplasm Metastasis
Survival Rate
Treatment Outcome